SLC16A3 as an immunosuppressive Kupffer cell marker predicts poor prognosis in HBV-positive hepatocellular carcinoma.

J Transl Med · 2025 · PMC12406350 · PMID 40898206

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

1 B analysis demonstrated that SLC16A3, SLC16A4, SLC16A5, SLC16A7, SLC16A8, SLC16A9, and SLC16A12 showed a trend of high expression in HBV negativepositive HCC patient.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.